Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Bacteremia and urogenital infection with Actinomyces urogenitalis following prolonged urinary retention

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Two cases of tick-borne transmitted tularemia on Southern Zealand, Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Analysis of proximal bone margins in diabetic foot osteomyelitis by conventional culture, DNA sequencing and microscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. L-serine: a neglected amino acid with a potential therapeutic role in diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  5. Erythrocytes restrict microvesicle-induced production of reactive oxygen species by polymorphonuclear leukocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Persistent severe postoperative hypotension after pancreaticoduodenectomy is related to increased inflammatory response

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions of pancreatic ductal adenocarcinoma (PDAC). Current edition of WHO Classification of Tumors of the Digestive System recognizes four different subtypes (gastric, intestinal, pancreatobiliary, and oncocytic) and recommends analysis of mucin expression (MUC1, MUC2, MUC5AC, MUC6) as well as evaluation of architectural and cell differentiation patterns for correct classification. However, there is no consensus on MUC1 expression of IPMN-lesions in the literature. Current recommendations are based on studies where antibodies against the core MUC1 protein or sialylated MUC1 (tumor associated MUC1), not the fully glycosylated MUC1 were used. We have recently reported that MUC1 is strongly expressed in both gastric and intestinal types IPMN specimens from the cystic wall, obtained by endoscopic ultrasound guided microbiopsy procedure. We have used a commercial MUC1 antibody, validated and recommended for diagnostic use, which recognizes fully glycosylated MUC1. Based on the above, we propose a revision of the WHO Classification, specifying that antibodies against tumor associated MUC1 should be used for IPMN subtyping.

Original languageEnglish
JournalAPMIS - Journal of Pathology, Microbiology and Immunology
Volume127
Issue number1
Pages (from-to)27-32
Number of pages6
ISSN0903-4641
DOIs
Publication statusPublished - Jan 2019

    Research areas

  • Gastrointestinal pathology, IPMN subtyping, MUC1, pancreas cancer, pathology of tumors, prognostic markers

ID: 55881671